These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32601799)

  • 21. Clinicopathological significance and prognostic role of tumor-infiltrating lymphocytes in colorectal cancer.
    Ko YS; Pyo JS
    Int J Biol Markers; 2019 Jun; 34(2):132-138. PubMed ID: 30852949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis.
    Höppener DJ; Nierop PMH; Hof J; Sideras K; Zhou G; Visser L; Gouw ASH; de Jong KP; Sprengers D; Kwekkeboom J; Vermeulen PB; Grünhagen DJ; Verhoef C
    Br J Cancer; 2020 Jul; 123(2):196-206. PubMed ID: 32418992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 24. Low infiltration of peritumoral regulatory T cells predicts worse outcome following resection of colorectal liver metastases.
    Nakagawa K; Tanaka K; Homma Y; Nojiri K; Kumamoto T; Takeda K; Endo I
    Ann Surg Oncol; 2015 Jan; 22(1):180-6. PubMed ID: 25120248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation.
    Itoh S; Yoshizumi T; Yugawa K; Imai D; Yoshiya S; Takeishi K; Toshima T; Harada N; Ikegami T; Soejima Y; Kohashi K; Oda Y; Mori M
    Hepatology; 2020 Dec; 72(6):1987-1999. PubMed ID: 32112577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value.
    Barnhill R; van Dam PJ; Vermeulen P; Champenois G; Nicolas A; Rawson RV; Wilmott JS; Thompson JF; Long GV; Cassoux N; Roman-Roman S; Busam KJ; Scolyer RA; Lazar AJ; Lugassy C
    J Pathol Clin Res; 2020 Jul; 6(3):195-206. PubMed ID: 32304183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis.
    Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Wang K; Xing BC
    J Surg Oncol; 2021 Sep; 124(4):619-626. PubMed ID: 34081792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathological growth patterns of resected non-colorectal, non-neuroendocrine liver metastases: a retrospective multicenter study.
    Meyer Y; Bohlok A; Höppener D; Galjart B; Doukas M; Grünhagen DJ; Labar A; Lucidi V; Vermeulen PB; Verhoef C; Donckier V
    Clin Exp Metastasis; 2022 Jun; 39(3):433-442. PubMed ID: 35124739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor biology reflected by histological growth pattern is more important than surgical margin for the prognosis of patients undergoing resection of colorectal liver metastases.
    Bohlok A; Inchiostro L; Lucidi V; Vankerckhove S; Hendlisz A; Van Laethem JL; Craciun L; Demetter P; Larsimont D; Dirix L; Vermeulen P; Donckier V
    Eur J Surg Oncol; 2023 Jan; 49(1):217-224. PubMed ID: 36031469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Metformin Use on Survival in Patients Undergoing Liver Resection for Colorectal Cancer Metastases.
    Kaltenmeier C; Morocco B; Yazdani H; Reitz K; Meyer K; Molinari M; Geller D; Tohme S
    Am Surg; 2021 Nov; 87(11):1766-1774. PubMed ID: 34766506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
    Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
    Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.
    Watanabe A; Araki K; Harimoto N; Kubo N; Igarashi T; Ishii N; Yamanaka T; Hagiwara K; Kuwano H; Shirabe K
    Int J Clin Oncol; 2018 Aug; 23(4):689-697. PubMed ID: 29574651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases.
    Buisman FE; van der Stok EP; Galjart B; Vermeulen PB; Balachandran VP; Coebergh van den Braak RRJ; Creasy JM; Höppener DJ; Jarnagin WR; Kingham TP; Nierop PMH; Sadot E; Shia J; Groot Koerkamp B; Grünhagen DJ; D'Angelica M; Verhoef C
    Clin Exp Metastasis; 2020 Oct; 37(5):593-605. PubMed ID: 32691187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical risk score predicts the effectiveness of adjuvant chemotherapy for colorectal liver metastasis.
    Nakai T; Ishikawa H; Tokoro T; Okuno K
    World J Surg; 2015 Jun; 39(6):1527-36. PubMed ID: 25677009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathological growth patterns and positive margins after resection of colorectal liver metastases.
    Nierop PMH; Höppener DJ; van der Stok EP; Galjart B; Buisman FE; Balachandran VP; Jarnagin WR; Kingham TP; Allen PJ; Shia J; Vermeulen PB; Groot Koerkamp B; Grünhagen DJ; Verhoef C; D'Angelica MI
    HPB (Oxford); 2020 Jun; 22(6):911-919. PubMed ID: 31735649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of poorly differentiated clusters in the primary tumor in patients undergoing hepatectomy for colorectal liver metastasis.
    Ueno H; Konishi T; Ishikawa Y; Shimazaki H; Ueno M; Aosasa S; Saiura A; Hase K; Yamamoto J
    Surgery; 2015 May; 157(5):899-908. PubMed ID: 25731780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Alcoholic Fatty Liver Disease May Be a Risk Factor for Liver Metastasis After Radical Surgery for Colorectal Cancer: A Retrospective Study.
    Miyata T; Shinden Y; Motoyama S; Sannomiya Y; Tamezawa H; Nagayama T; Nishiki H; Hashimoto A; Kaida D; Fujita H; Ueda N; Takamura H
    J Gastrointest Cancer; 2024 Jun; 55(2):932-939. PubMed ID: 38502514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
    Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
    Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.
    Sasaki K; Andreatos N; Margonis GA; He J; Weiss M; Johnston F; Wolfgang C; Antoniou E; Pikoulis E; Pawlik TM
    J Surg Oncol; 2016 Dec; 114(7):803-809. PubMed ID: 27792291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.